Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Proposed subtypes of post‐COVID‐19 syndrome (or long‐COVID) and their respective potential therapies
The effects of coronavirus disease 2019 (COVID‐19), a highly transmissible infectious
respiratory disease that has initiated an ongoing pandemic since early 2020, do not always …
respiratory disease that has initiated an ongoing pandemic since early 2020, do not always …
Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis
TI Hariyanto, KV Japar, F Kwenandar, V Damay… - The American journal of …, 2021 - Elsevier
Background Laboratory testing is commonly performed in patients with COVID-19. Each of
the laboratory parameters has potential value for risk stratification and prediction of COVID …
the laboratory parameters has potential value for risk stratification and prediction of COVID …
Machine learning prediction for mortality of patients diagnosed with COVID-19: a nationwide Korean cohort study
C An, H Lim, DW Kim, JH Chang, YJ Choi, SW Kim - Scientific reports, 2020 - nature.com
The rapid spread of COVID-19 has resulted in the shortage of medical resources, which
necessitates accurate prognosis prediction to triage patients effectively. This study used the …
necessitates accurate prognosis prediction to triage patients effectively. This study used the …
COVID-19 and diabetes
AK Singh, K Khunti - Annual review of medicine, 2022 - annualreviews.org
The prevalence of diabetes in people with coronavirus disease 2019 (COVID-19), caused by
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has varied worldwide …
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has varied worldwide …
Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications
Background Our understanding of the pathophysiology of the COVID-19 manifestations and
evolution has improved over the past 10 months, but the reasons why evolution is more …
evolution has improved over the past 10 months, but the reasons why evolution is more …
Metformin use is associated with reduced mortality in a diverse population with COVID-19 and diabetes
Background Coronavirus disease-2019 (COVID-19) is a growing pandemic with an
increasing death toll that has been linked to various comorbidities as well as racial disparity …
increasing death toll that has been linked to various comorbidities as well as racial disparity …
COVID-19 in relation to hyperglycemia and diabetes mellitus
Coronavirus disease 2019 (COVID-19), triggered by the severe acute respiratory syndrome-
coronavirus 2 (SARS-CoV-2), may lead to extrapulmonary manifestations like diabetes …
coronavirus 2 (SARS-CoV-2), may lead to extrapulmonary manifestations like diabetes …
Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis
Background Diabetes is an independent predictor of poor outcomes in patients with COVID-
19. We compared the effects of the preadmission use of antidiabetic medications on the in …
19. We compared the effects of the preadmission use of antidiabetic medications on the in …
[HTML][HTML] Diabetes and COVID-19: short-and long-term consequences
C Steenblock, M Hassanein, EG Khan… - Hormone and …, 2022 - thieme-connect.com
When the corona pandemic commenced more than two years ago, it was quickly recognized
that people with metabolic diseases show an augmented risk of severe COVID-19 and an …
that people with metabolic diseases show an augmented risk of severe COVID-19 and an …
Therapeutic potential of metformin in COVID-19: reasoning for its protective role
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections present with
increased disease severity and poor clinical outcomes in diabetic patients compared with …
increased disease severity and poor clinical outcomes in diabetic patients compared with …